Lexology February 19, 2025
Donald Trump’s return to the White House has brought with it some fast-paced changes to global politics and markets, and the biotech industry has not been left out from the speculation about the future. The UK’s BioIndustry Association (BIA) recently hosted a panel discussion between industry leaders about the potential impacts and opportunities that Trump’s return to power may present, as reported here: https://www.linkedin.com/pulse/trump-effect-what-does-mean-uk-biotech-bioindustry-ya3ie/.
It is reassuring to note that there is optimism for the state of the UK’s biotech funding, with the UK’s venture capital (VC) funding increasing significantly in recent years. This was considered to be a good sign of the resilience of the UK’s biotech industry in these changing times.
The US market seems to be less...
Today's Sponsors
Today's Sponsor